Previous studies found that OX40/OX40L is correlated with multiple rheumatic diseases and has the potential to be therapeutic targets (Laustsen et al., 2014; Jacquemin et al., 2018; Fu et al., 2020). This evidence concerns the gene TNFSF4 and rheumatic disorder.